Radium-223 dichloride with enzalutamide for treating asymptomatic or mildly symptomatic hormone-relapsed metastatic prostate cancer with bone metastases [ID6512]

• Awaiting development
• Reference number: GID-TA11657
• Expected publication date:  07 April 2027